Milliken & Company Launches Millad ClearX™ 9000: The Clear Choice for Polypropylene

Delivers exceptional clarity with lower additive levels, streamlining production and expanding formulation options for converters and resin producers

SPARTANBURG, S.C., Oct. 7, 2025 /PRNewswire/ -- Milliken & Company proudly announces the launch of Millad ClearX™ 9000, the next generation clarifying technology for polypropylene (PP) developed to deliver ultra-clear transparency at reduced additive loading levels. Ideal for food packaging, home storage, and medical applications, Millad ClearX™ 9000 sets a new standard for value, aesthetics, and operational efficiency in transparent PP applications.

Building on the proven Millad^® platform, Millad ClearX™ 9000 provides manufacturers with an advanced solution that:

• Achieves ultra-clear PP using more efficient loading levels, reducing the amount of clarifying additives needed.
• Lowers extraction and migration rates in PP packaging and parts—critical for food-contact and medical applications.
• Improves processing compatibility compared to prior generations, supporting enhanced operational efficiency.
• Eliminates the need for segregated virgin and PCR resin streams, enabling greater composition flexibility.

"Millad ClearX™ 9000 is a breakthrough for the polypropylene industry, delivering ultra-clear transparency with less clarifying additive and greater flexibility for our customers," said Wim Van De Velde, SVP and Managing Director of Milliken's plastic additives business. "This launch reflects Milliken's ongoing commitment to advancing material science and helping our partners meet evolving market demands."

Millad ClearX™ 9000 has broad FDA conditions of use approval (A-J), opening doors for its use across a wide spectrum of food-contact applications. By enhancing additive compatibility, it helps resin producers and converters experience less downtime, less waste, and quicker changeovers—delivering measurable improvements in manufacturing efficiency. The technology also allows for improved compatibility with other Millad clarifying agents, giving producers the flexibility to optimize formulations for both virgin and post-consumer recycled (PCR) PP, supporting sustainability initiatives.

"Our team developed Millad ClearX™ 9000 to address the growing need for clarity and efficiency in polypropylene applications," said Bhavesh Gandhi, Global Product Line Manager of Milliken's plastic additives business. "By reducing additive loading and migration rates, we're helping our customers create products that are not only visually appealing but also meet the highest standards for food and medical use."

Milliken, through its Millad platform, pioneered the application of clarifying agents to create transparent PP parts and packaging incorporating PCR content, and the company's latest clarifying technology builds on that legacy. To learn more about Millad ClearX™ 9000, visit milliken.com.

About Milliken  

Milliken & Company is a global manufacturing leader whose focus on materials science delivers tomorrow's breakthroughs today. From industry-leading molecules to sustainable innovations, Milliken creates products that enhance people's lives and deliver solutions for its customers and communities. Drawing on thousands of patents and a portfolio with applications across the textile, flooring, chemical and healthcare businesses, the company harnesses a shared sense of integrity and excellence to positively impact the world for generations. Discover more about Milliken's curious minds and inspired solutions at milliken.com and on Facebook, Instagram, and LinkedIn.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Milliken & Company Launches Millad ClearX™ 9000: The Clear Choice for Polypropylene

NEW YORK, Aug. 25, 2026 /PRNewswire/ -- Dimora Medical, a continuous innovator in high-end medical care supplies, today announced price reductions across its entire MegaSorb™ wound dressing lineup—with select SKUs discounted by up to 29% to make advanced wound management solutions more accessible to a broader range of households. The move reflects the company's ongoing commitment to helping patients and caregivers access professional-grade wound care products while managing the growing financial pressures associated with healthcare and long-term recovery.

Industry research indicates that wound management is increasingly shifting from hospitals and clinical settings to home-based care, driven by factors including shorter hospital stays, an aging population, and growing demand for effective treatment outside traditional healthcare facilities. At the same time, healthcare expenditures in the United States continue to rise, placing greater emphasis on solutions that balance clinical performance with affordability.

Through the new pricing initiative, Dimora Medical aims to make advanced wound management more accessible to patients and caregivers. Supported by continued business growth and operational efficiencies, the initiative allows more consumers to benefit from high-performance wound care solutions at a lower cost.

Beyond the purchase price, the overall cost of wound care is often influenced by product performance. Introduced earlier this year as Dimora Medical's proprietary silicone foam dressing technology platform, MegaSorb™ features a Dual-Action Absorption System built on a highly porous foam structure designed for rapid fluid absorption and retention. Capable of absorbing up to 15 times its own weight in fluid, MegaSorb™ dressings help manage moderate-to-heavily exuding wounds, reducing leakage risk and supporting a more stable wound environment. Their high absorbency may also help minimize dressing changes, contributing to more efficient use of wound care supplies over time.

The new pricing initiative for the MegaSorb™ dressings underscores Dimora Medical's commitment to improving access to professional-grade wound care. To support this effort, select sacral dressing products, including the 7"×7" and 6"×6" formats, will be offered at 15% off on Amazon from August 24 to September 6. By bringing together affordability, performance, and ease of use, the initiative supports families navigating recovery and ongoing care at home.

Moving forward, Dimora Medical will continue advancing product innovation and operational efficiencies to make home wound management simpler, more effective, and more accessible—upholding its core mission to make home care easy.

For more information, please visit: https://dimoramedical.com/.

Media Contact

Dimora Medical

support@dimoramedical.com 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Dimora Medical Introduces New Pricing for MegaSorb™ Dressings, Expanding Access to Professional-Grade Wound Care